Advertisement

HIV in Central Asia: Tajikistan, Uzbekistan and Kyrgyzstan

  • Daniel Wolfe
  • Richard Elovich
  • Azizbek Boltaev
  • Dilshod Pulatov

Keywords

Harm Reduction Global Fund Needle Exchange Substitution Treatment Kyrgyz Republic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bashmakova, L., Kurmanova, G., Kashkarev, A., & Shapiro, B. (2003). AIDS in Kyrgyzstan: Five Years of Resistance. Bishkek: Goverment of the Kyrgyz Republic/UNDP/UNAIDS.Google Scholar
  2. Boltaev, A. (2003). Cost-Effectiveness of Needle Exchange Programs among IDUs in Uzbekistan. Paper presented at the IREX conference on Dynamic Communications Strategies and Tools, December 2003, Washington DC, USA.Google Scholar
  3. Boltaev, A. (2005). Access to health care for drug users as an effective tool for HIV control in Uzbekistan. Paper presented at the International Conference on Reduction of Drug-Related Harm, March 20–24, 2005, Belfast, Ireland.Google Scholar
  4. Boltaev, A. (2006). HIV and drug situation and response analysis in Uzbekistan. Tashkent: Central Asian Regional HIV/AIDS Programme Uzbekistan Office.Google Scholar
  5. Boltaev, A., Bakhtiyor, S., Gromo, I., Lefebrvre, R., & Gastfriend, D. (2004). Comparative Analyses of ASAM PPC-2R Software derived level of care with actual clients on mandatory substance addiction treatment in Bukhara. Paper presented at the Annual Meeting of the International Society of Addiction Medicine, June 2004, Helsinki, Finland.Google Scholar
  6. CARHAP. (2006a). Final Rapid Assessment Report: Republic of Tajikistan. Dushanbe: Open Society Institute Assistance Foundation.Google Scholar
  7. CARHAP. (2006b). Rapid Assessment Final Report: Kyrgyzstan. Bishkek: Central Asian Regional HIV/AIDS Program.Google Scholar
  8. CARHAP. (2006c). Rapid Assessment in Uzbekistan: Final Consolidated Report. Tashkent: Central Asia Regional HIV/AIDS Programme.Google Scholar
  9. CARHAP. (2006d). Rapid Assessment Report: Ferghana and Samarkand Oblast. Tashkent: Central Asian Regional HIV/AIDS Programme Uzbekistan Office.Google Scholar
  10. CARHAP. (2006e). Rapid Assessment Report: Tashkent and Surkhandarya Oblasts. Tashkent: Central Asian Regional HIV/AIDS Programme Uzbekistan Office.Google Scholar
  11. CCM of the Kyrgyz Republic. (2002). Kyrgyzstan Application to the Global Fund – Round 4. (Retrieved January 17, 2006); from www.theglobalfund.org.
  12. Center for Substance Abuse Treatment. (2006). TIP 19: Detoxification from alcohol and other drugs. Washington, DC: Substance Abuse and Mental Health Services Administration.Google Scholar
  13. DDRP. (2006). “Break the Cycle” Program. Newsletter of the USAID funded drug demand reduction program in Uzbekistan, Tajikistan, and the Ferghana Valley Region of Kyrgyzstan (May 2006), 6–7.Google Scholar
  14. Drug Control Agency of Tajikistan. (2007). Narcomania is a terrible harm! (narcomania eta strasnoe zlo) (in Russian). (Retrieved April 1, 2007); from www.akn.tj./profil.htm.
  15. Elovich, R. (2007). Narcology Observed: Civil Society and Drug Treatment in Central Asia (unpublished manuscript).Google Scholar
  16. EMCDDA. (2001). Substitution Treatment: A Key Component of Drug Treatment. Lisbon, Portugal: European Monitoring Center for Drugs and Drug Addiction.Google Scholar
  17. Estebesova, B. (2003). The Role of NGOs in Implementation of the Harm Reduction Programs for Drug Dependency in the Kyrgyz Republic, In T. Asanov (Ed.), Decreasing Vulnerability of Injection Drug Users in the Kyrgyz Republic. Osh: Kyrgyz Republic.Google Scholar
  18. Falkingham, J. (2002). Poverty, Affordability, and Access to Health Care. In M. Mckee, J. Healy & J. Falkingham (Eds.), Health Care in Central Asia (pp. 31–41). Philadelphia: Open University.Google Scholar
  19. Friedman, S., de Jong, W., Rossi, D., Touze, G., Rockwell, R., Des Jarlais, D., & Elovich, R. (2007). Harm reduction theory: Users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizer of users' groups. International Journal of Drug Policy, 18 (2), 107–117.CrossRefPubMedGoogle Scholar
  20. Gerstein, D., & Harwood, H. (1990). Treating drug problems. Washington, DC: Institute of Medicine/National Academy Press.Google Scholar
  21. Gilinsky, Y., & Zobnev, V. (1998). The drug treatment system in Russia: past and present, problems and prospects. In H. Klingemann & G. Hunt (Eds.), Drug treatment systems in an international perspective: Drugs, demons, and delinquents (pp. 117–123). Thousand Oaks, CA: Sage Publications.Google Scholar
  22. Godinho, J., Renton, A., Vinogradov, V., Novotyn, T., Rivers, M.J., Gotsadze, G., & Bravo, M. (2005). Reversing the Tide: Priorities for HIV/AIDS Prevention in Central Asia. Washington DC: The World Bank.Google Scholar
  23. Gotsadze, G. (2004). Central Asia HIV/AIDS Control Project: Social and Institutional Assessment: Report to the Department for International Development and the World Bank (Unpublished document).Google Scholar
  24. Kuehnast, K. R., & Dudwick, N. (2004). Better a hundred friends than a hundred rubles? Social networks in transition – the Kyrgyz Republic. Washington, DC: World Bank.CrossRefGoogle Scholar
  25. Kurbanov, F., Kondo, M., Tanaka, Y., Zalalieva, M., Giasova, G., Shima, T., Jounai, N., Yuldasheva, N., Ruzibakiev, R., Mizokami, M., & Imai, M. (2003). Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses. AIDS Res Hum Retroviruses, 19(9), 731–738.CrossRefPubMedGoogle Scholar
  26. Kyrgyz Republic. (2001). State Program on Prevention of HIV/AIDS, infections transmitted sexually and through injecting ways for 2001–2005. Bishkek: Government of the Kyrgyz Republic (Governmental Decree no. 785).Google Scholar
  27. Kyrgyz Republic. (2006). State Program on HIV/AIDS Epidemic Prevention and its Social-economic consequences in the Kyrgyz Republic for 2006–2010. Bishkek: Government of the Kyrgyz Republic (Resolution no. 498).Google Scholar
  28. Kyrgyz Republic. (2007). Global Fund grant performance report – 25 February. (Retrieved March 31, 2007); www.theglobalfund.org.
  29. Lapytov, A., Nidoev, S., Ramazanov, S., Semikina, E., Muravleva, O., Shirinbekova, N, & Djamalov, P. (2006). Annual Report: Tajikistan Drug Situation 2005. Dushanbe: United Nations Development Programme.Google Scholar
  30. Mounier, S., Mckee, M., Atun, R., & Coker, R. (2007). HIV/AIDS in Central Asia. In J. Twigg (Ed.), HIV/AIDS in Russia and Eurasia (Vol. 2). New York: Palgrave Macmillan.Google Scholar
  31. NCC of Tajikistan. (2004). Round Four Proposal to the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Dushanbe: National Coordination Committee to Fight AIDS, Tuberculosis and Malaria of Tajikistan.Google Scholar
  32. NCC of Tajikistan. (2006). Round Six Proposal to the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Dushanbe: National Coordination Committee to Fight AIDS, Tuberculosis and Malaria of Tajikistan.Google Scholar
  33. Needle, R., Burrows, D., Friedman, S., Dorabjee, J., Badrieva, L., Suresh Kumar, M., Nigro, L., Manning, G., & Latkin, C. (2004). Evidence for action: Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. Geneva: World Health Organization.Google Scholar
  34. Olimova, S., & Bosc, I. (2003). Labour Migration from Tajikistan. Dushanbe: International Organization for Migration.Google Scholar
  35. Open Society Institute. (2003). Consolidated assessment report for Drug Demand Reduction Program in Uzbekistan and Tajikistan. Tashkent: Drug Demand Reduction Program.Google Scholar
  36. Parfitt, T. (2003). Drug addiction and HIV infection on rise in Tajikistan. Lancet, 362(9391), 1206.Google Scholar
  37. Pomfret, R. (2002). Macroeconomic Pressures. In M. Mckee, J. Healy & J. Falkingham (Eds.), Health Care in Central Asia (pp. 31–41). Philadelphia: Open University.Google Scholar
  38. Renton, A., Gzirisvilli, D., Gotsadze, G., & Godinho, J. (2006). Epidemics of HIV and sexually transmitted infections in Central Asia: Trends, drivers and priorities for control. International Journal of Drug Policy, 17, 494–503.CrossRefGoogle Scholar
  39. Republic of Tajikistan. (2002). Strategic plan: National Response to the HIV/AIDS epidemics in the Republic of Tajikistan 2002–2004. Dushanbe.Google Scholar
  40. Republic of Tajikistan. (2007a). Global Fund grant performance report – 10 January. (Retrieved March 31, 2007); www.theglobalfund.org.
  41. Republic of Tajikistan. (2007b). Strategic plan on the counteraction of the HIV/AIDS epidemic in the Republic of Tajikistan. Dushanbe.Google Scholar
  42. Republic of Uzbekistan. (2007). Global Fund grant performance report – 13 February. (Retrieved March 31, 2007); www.theglobalfund.org.
  43. Republican Emergency Anti-Epidemic Commission. (2003). Scaling Up the Response to HIV/AIDS and Tuberculosis in Uzbekistan: A focus on Vulnerable Populations 2004–2008 (Round 4 Application to the Global Fund to Fight AIDS, Tuberculosis and Malaria). Tashkent: Sub-Commission of the Republican Emergency Anti-Epidemic Commission for HIV/AIDS and TB.Google Scholar
  44. Rhodes, T., Stimson, G. V., Crofts, N., Ball, A., Dehne, K., & Khodakevich, L. (1999). Drug injecting, rapid HIV spread, and the `risk environment': implications for assessment and response. AIDS, 13 Suppl A, S259–269.PubMedGoogle Scholar
  45. Rouse, T., & Unnithan, N. (1993). Comparative ideologies and alcoholism: The Protestant and proletarian ethics. Social Problems, 40(2), 213–227.CrossRefGoogle Scholar
  46. Soros Foundation Kyrgyzstan. (2007). Advancing the health and well-being of drug users in the Kyrgyz Republic: Donor mapping and recommendations for further action. Bishkek: Soros Foundation Kyrgyzstan (in press).Google Scholar
  47. Stachowiak, J. A., Tishkova, F. K., Strathdee, S. A., Stibich, M. A., Latypov, A., Mogilnii, V., & Beyrer, C. (2006). Marked ethnic differences in HIV prevalence and risk behaviors among injection drug users in Dushanbe, Tajikistan, 2004. Drug Alcohol Depend, 82 Suppl 1, S7–14.CrossRefGoogle Scholar
  48. Subata, E., & Pkhakadze G. (2006). Evaluation of Pilot Methadone Maintenance Treatment in the Kyrgyz Republic. Bishkek: United Nations Development Program/Joint United Nations Programme on HIV/AIDS.Google Scholar
  49. SWAN. (2007). Swan Alert: Police Raids and Arrests in Kyrgyzstan [Electronic Version]. Sex Workers Rights Advocacy Network in Central and Eastern Europe and Central Asia Newsletter, 2. (Retrieved March 30, 2007); www.tasz.hu/index.php.
  50. Todd, C. S., Earhart, K. C., Botros, B. A., Khakimov, M. M., Giyasova, G. M., Bautista, C. T., Carr, J. K., & Sanchez, J. L. (2007). Prevalence and correlates of risky sexual behaviors among injection drug users in Tashkent, Uzbekistan. AIDS Care, 19(1), 122–129.CrossRefPubMedGoogle Scholar
  51. UN Committee on Economic and Social Rights. (2006). E/C.12/TJK/CO/1. Comments on Tajikistan. Geneva: United Nations.Google Scholar
  52. UNAIDS. (2006). UNAIDS Best Practice Colection: HIV and sexually transmitted infection prevention among sex workers in Eastern Europe and Central Asia. Geneva: Joint United Nations Programme on HIV/AIDS.Google Scholar
  53. UNDP. (2006). Human Development Report 2006. New York: United Nations Development Programme.Google Scholar
  54. UNODC. (2002). Money Laundering and Related Issues in Uzbekistan. Vienna: United Nations Office on Drugs and Crime.Google Scholar
  55. UNODC. (2006). Drug Abuse in Central Asia: Trends in treatment demand, 2003–2005. Vienna: United Nations Office on Drugs and Crime: Global Assessment Programme on Drug Abuse.Google Scholar
  56. UNODCCP. (2003). Rapid Situation Assessment on drug abuse in the Central Asian countries (Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan). Tashkent: United Nations Office on Drug Control and Crime Prevention.Google Scholar
  57. USAID. (2001). The 2001 NGO Sustainability Index for Central and Eastern Europe and Eurasia. Washington, DC: United States Agency for International Development, Bureau for Europe and Eurasia office of Democracy and Governance.Google Scholar
  58. Van der Veur, D. (2004). Kyrgyzstan: “The country of Human Rights”…but not for homosexuals. Amsterdam: COC Netherlands/HIVOS.Google Scholar
  59. Wolfe, D. (2005). Pointing the way: Harm Reduction in the Kyrgyz Republic. Bishkek: Harm Reduction Association of Kyrgyzstan.Google Scholar
  60. Wolfe, D. (2007). Antiretroviral Treatment for Injecting Drug Users: Paradoxes of treatment in Asia and the former Soviet Union. International Journal of Drug Policy, 18 (4), 246–254.CrossRefPubMedGoogle Scholar
  61. Zelichenko, A. (2004). Afghan Narcoexpansion of the 1990s. Bishkek: Izsdanye.Google Scholar
  62. Zelichenko, A. (2006). Rapid Assessment in Prisons. Bishkek: Central Asia HIV/AIDS Programme.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Daniel Wolfe
    • 1
  • Richard Elovich
    • 2
  • Azizbek Boltaev
    • 3
  • Dilshod Pulatov
    • 4
  1. 1.Deputy Director, International Harm Reduction Development ProgramOpen Society Institute New YorkNew YorkUSA
  2. 2.National Development and Research Institutes, Inc. New YorkNew YorkUSA
  3. 3.Regional Harm Reduction Adviser Central Asian Regional HIV/AIDS Program, GRM InternationalUzbekistan
  4. 4.The Head, Expert CommissionUnder Coordination Counsel on Drugs and HIV Prevention Sogd DistrictTajikistan

Personalised recommendations